IPM researchers publish scientific and technical articles on a variety of topics from product development and clinical trial results to regulatory policy. Scroll through or use the Filtered Search in the left sidebar to locate articles by keyword, author, journal name or year published.
HIV Incidence Remains High in KwaZulu-Natal, South Africa: Evidence from Three Districts.
Nel A, Mabude Z, Smit J, Kotze P, Arbuckle D, Wu J, van Niekerk N, van de Wijgert J. PLOS ONE. 7, no. 4 (April 2012): e35278.
Acceptability of Vaginal Film, Soft-Gel Capsule, and Tablet as Potential Microbicide Delivery Methods Among African Women.
Nel A., Mitchnick L., Risha P., Muungo LTM., Norick P. Journal of Women's Health 20, no. 8 (August 2011): 1207-1214.
HIV Prevalence and Incidence among Sexually Active Females in Two Districts of South Africa to Determine Microbicide Trial Feasibility.
Nel A., Louw C., Hellstrom E., Braunstein SL., Treadwell I., Marais M., de Villiers M., Hugo J., Paschke I., Andersen C., van de Wijgert J. PLoS ONE 6, no. 8 (August 2011): e21528.
Pharmacokinetic assessment of dapivirine vaginal microbicide gel in healthy, HIV-negative women.
Nel A.M., Coplan P., Smythe S.C., McCord K., Mitchnick M., Romano J. Accepted for publication in AIDS Research and Human Retroviruses. July 2010
Pharmacokinetics of two dapivirine vaginal microbicide gels and their safety vs. hydroxyethyl cellulose-based universal placebo gel.
Nel A., Smythe S., Habibi S., Romano J. Journal of Acquired Immune Deficiency Syndromes. June 2010.
Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers.
Luchters S.M., Vanden Broeck D., Chersich M.F., Nel A., Delva W., Mandaliya K., Depuydt C.E., Claeys P., Bogers J.P., Temmerman M. BMC Infectious Diseases 10, no. 18 (2010).
Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women.
Nel A., Smythe S., Young K., Malcolm K., McCoy C., Rosenberg Z., Romano J. Journal of Acquired Immune Deficiency Syndromes 51, no. 4 (August 2009): 416-23
Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy HIV-negative women.
Nel A.M., Coplan P., van de Wijgert J.H., Kapiga S.H., von Mollendorf C., Geubbels E., Vyankandondera J., Rees H.V., Masenga G., Kiwelu I., Moyes J., Smythe S.C. AIDS 23, no. 12 (July 2009): 1531-8.
Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring.
Romano J., Variano B., Coplan P., Van Roey J., Douville K., Rosenberg Z., Temmerman M., Verstraelen H., Van Bortel L., Weyers S., Mitchnick M. AIDS Research and Human Retroviruses 25, no. 5 (2009):...
Modeling the social context of microbicide use.
Simons-Rudolph A.P., Woodsong C., Koo H.P. The Microbicide Quarterly 6, no. 4 (2008): 1-11.